personalized glp-1 treatment Starting GLP-1 medications at lower

Sitagliptin works by inhibiting the DPP-4 enzyme that destroys glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) hormones, allowing both to function more effectively

And critically, it acts on the hypothalamus to reduce appetite, creating powerful satiety signals that make people eat significantly less without feeling deprived

Phathom supports ongoing scientific research aimed at expanding understanding of acid-related conditions like GERD and advancing #gastroenterology care

To determine whether peptide therapy is a good fit for your specific situation, schedule a consultation with a DripGym physician